Tempest Therapeutics
(NASDAQ) TPST
Tempest Therapeutics Financials at a Glance
Market Cap
$22.66M
Revenue (TTM)
$0.00
Net Income (TTM)
$26.26M
EPS (TTM)
$-6.84
P/E Ratio
-0.23
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$2.05
Volume
1,704,943.635
Open
$1.63
Price
$2.05
Volume
1,704,943.635
Open
$1.63
Previous Close
$2.05
Daily Range
$1.59 - $2.15
52-Week Range
$1.50 - $12.23
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$2.05
Volume
1,704,943.635
Open
$1.63
Previous Close
$2.05
Daily Range
$1.59 - $2.15
52-Week Range
$1.50 - $12.23
TPST News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tempest Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Stephen R. Brady
Website
www.tempesttx.comHeadquarters
Brisbane, CA 94080, US
TPST Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-204%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-4.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$22.66M
Shares Outstanding
14.34M
Volume
1.70M
Short Interest
0.00%
Avg. Volume
148.56K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$26.57M
EBITDA
$25.79M
Operating Cash Flow
$26.82M
Capital Expenditure
$0.00
Free Cash Flow
$26.82M
Cash & ST Invst.
$7.71M
Total Debt
$8.14M
Tempest Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$65.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$22.66M
N/A
Market Cap/Employee
$944.31K
N/A
Employees
24
N/A
Net Income
$4.02M
+70.9%
EBITDA
$3.96M
+70.7%
Quarterly Fundamentals
Net Cash
$434.00K
-102.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$6.95M
-14.7%
Short Term Debt
$1.19M
-83.5%
Return on Assets
-1.55%
N/A
Return on Invested Capital
-1.95%
N/A
Free Cash Flow
$24.50M
-141.4%
Operating Cash Flow
$24.50M
-141.4%